Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

FDA proposes rule over record-keeping for vape makers

Published 09/20/2019, 10:25 AM
Updated 09/20/2019, 10:31 AM
FDA proposes rule over record-keeping for vape makers

(Reuters) - The U.S. Food and Drug Administration on Friday issued a proposed rule for e-cigarette makers, requiring them to maintain records related to the legal marketing status of their products.

When finalized, the rule would also help to ensure that e-cigarette applications by manufacturers contain information on the product's potential public health benefits and harms, the FDA said.

The agency's proposal follows a rise in popularity of the e-cigarettes among the youth and a widening outbreak of severe lung-related illnesses tied to vaping that has affected possibly 530 people.

A U.S. District Court judge in Maryland in July issued an order that would require makers of tobacco products, including e-cigarette makers, to file the applications by May 12, 2020.

Juul Labs Inc, the market leader in the U.S. e-cigarette market, was warned by the FDA over marketing its vapes as safer than traditional cigarettes. The Federal Trade Commission is investigating the marketing practices of e-cigarette maker Juul Labs Inc.

The proposed rule also establishes procedures which the FDA would follow when reviewing the premarket tobacco product applications.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.